The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
Major Depressive Disorder
About this trial
This is an interventional treatment trial for Major Depressive Disorder focused on measuring Failure to Escitalopram
Eligibility Criteria
Inclusion Criteria: Primary DSM-IV diagnosis of Major Depressive episode of MDD without psychotic symptoms. Additional axis I diagnoses will be permitted only if they are identified as secondary diagnoses Ham-D 21 item score of greater than or equal to 18 Age 18 and above Ability and willingness to provide consent for participation Failure to respond to escitalopram Exclusion Criteria: Diagnosis of Bipolar Disorder or any psychotic disorder Alcohol or drug abuse or dependence currently or in the last 6 months A history of non-response or intolerance to sertraline at least 50 mg. for at least 4 weeks or more Concomitant use of another antidepressant or use of an antidepressant within 2 weeks of baseline (4 weeks for fluoxetine) Use within 1 week of baseline, or concomitant use of any psychotropics with the exception of zolpidem for sleep Use within 4 weeks of baseline or concomitant use of benzodiazepines with the exception of PRN use of diazepam 10 mg/day or its equivalent Presence of serious and/or unstable medical condition Score of 3 or 4 on the suicide item (item 3) of the Ham-D scale Known sensitivity of sertraline